Marc Lichtenfeld is a former Wall Street analyst and business journalist. He is a frequent speaker at investment conferences all over the world. Known for his contrarian recommendations, he broke several major stories on companies in the biotech sector. His investment approach blends thorough fundamental research with the timing tools of technical analysis. He views the market with a skeptical eye as a columnist and editor of several publishing companies. A highly-acclaimed author, his bestselling books were translated into different languages.